Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease

Código QR

Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease

BACKGROUND AND OBJECTIVE: Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common form of degenerative dementia with progressive loss of cognitive abilities and memory loss. AD is an irreversible, progressive chronic disease that it is the cause of behavior changes and deteriora...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	SM Hoseini, M Nobakht, P Mortazavi, B Esmailzade, N Rahbar-Rooshandel, SH Omidzahir
Formato:	article
Lenguaje:	EN FA
Publicado:	Babol University of Medical Sciences 2012
Materias:	alzheimers disease (ad) hippocampus beta-amyloid (abeta) memory neuropathological changes Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0bb7aa72dead4cac9f4ae4081aefe982
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Improved affinity selection using phage display technology and off-rate based selection
por: Yuan,Bin, et al.
Publicado: (2006)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
por: Raquel Sanchez-Varo, et al.
Publicado: (2021)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer’s Disease Using QEEG Features and Genetic Algorithm Heuristic
por: Nam Heon Kim, et al.
Publicado: (2021)

Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
por: Kanubaddi KR, et al.
Publicado: (2018)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun LP, et al.
Publicado: (2018)

A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
por: Xing Y, et al.
Publicado: (2017)

Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy
por: Sumonto Mitra, et al.
Publicado: (2021)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021)

Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints
por: Kim JW, et al.
Publicado: (2019)

Isoorientin Inhibits Amyloid β<sub>25–35</sub>-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway
por: Buyun Kim, et al.
Publicado: (2021)

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006)

The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
por: Javier Frontiñán-Rubio, et al.
Publicado: (2021)

Increased astrocyte representation in the hippocampus of 5xFAD mice
por: Jovanović Violeta, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation
por: Pandya V, et al.
Publicado: (2018)

Genes associated with Alzheimer's disease: an overview and current status
por: Giri M, et al.
Publicado: (2016)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Rebecca M. Parodi-Rullán, et al.
Publicado: (2021)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Amyloid-ß-peptide reduces copper(II) to copper(I) independent of its aggregation state
por: OPAZO,CARLOS, et al.
Publicado: (2000)

Hippocampus
Publicado: (1991)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Jatin Machhi, et al.
Publicado: (2021)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
por: I. K. Malashenkova, et al.
Publicado: (2018)

Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia
por: Zhang X
Publicado: (2020)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

Scopolamine Reduces the Density of M1 Muscarinic Neurons in Rats' Hippocampus
por: Jahanshahi,M, et al.
Publicado: (2013)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
por: Tosin A. Olasehinde, et al.
Publicado: (2019)

Amyloid
Publicado: (1994)

Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line
por: LIMA,ANDRÉA C PAULA, et al.
Publicado: (2008)

An insight into Alzheimer’s disease and its on-setting novel genes
por: Jaanaky Vigneswaran, et al.
Publicado: (2021)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Heeyoung Kang, et al.
Publicado: (2021)

Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
por: Taisei Tanaka, et al.
Publicado: (2021)

The Preventive and Treatment Effect of Urtica dioica on Astrocyte Density in the CA1 and CA3 Subfields of Hippocampus in STZ Induced Diabetic Rats
por: Golalipour,Mohammad Jafar, et al.
Publicado: (2013)

Alzheimer's patients detection using support vector machine (SVM) with quantitative analysis
por: Abhilash Sharma, et al.
Publicado: (2021)